KREBSBIO

KREBS BIOCHEMICALS & INDUSTRIES

Small Cap BSE: 524518 NSE: KREBSBIO
₹114.5
5 (4.57%)
As on 30 September, 2022 | 01:31

Krebs Biochemicals & Industries Share Price

Krebs Biochemicals & Industries Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in KREBS BIOCHEMICALS & INDUSTRIES

Start SIP

Krebs Biochemicals & Industries Share Returns

  • Over 1 Month -6.49%
  • Over 3 Month 7.15%
  • Over 6 Month -22.41%
  • Over 1 Year -35.81%

Krebs Biochemicals & Industries Key Statistics

P/E Ratio -5.7
PEG Ratio 0.1
Market Cap Cr 247
Price to Book Ratio -3.3
EPS -20.7
Dividend 0
Relative Strength Index 44.01
Money Flow Index 34.28
MACD Signal -0.14
Average True Range 5.78

Krebs Biochemicals & Industries Investment Rating

  • Master Rating:
  • Krebs Biocs.& Inds. has an operating revenue of Rs. 61.52 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of -84% needs improvement, NULL The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 21 which is a POOR score indicating inconsistency in earnings, a RS Rating of 14 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 124 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Krebs Biochemicals & Industries Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 10182212516
Operating Expenses Qtr Cr 172932201320
Operating Profit Qtr Cr -7-11-10-8-8-5
Depreciation Qtr Cr 221111
Interest Qtr Cr 002221
Tax Qtr Cr 000000
Net Profit Qtr Cr -8-11-13-11-9-7

Krebs Biochemicals & Industries Technicals

EMA & SMA

Current Price
113.9
4.4 (4.02%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 117.43
  • 50 Day
  • 117.46
  • 100 Day
  • 121.9
  • 200 Day
  • 139.35
  • 20 Day
  • 120.67
  • 50 Day
  • 116.67
  • 100 Day
  • 113.95
  • 200 Day
  • 139.33

Krebs Biochemicals & Industries Resistance and Support

PIVOT
₹109.82
Resistance
First Resistance 112.39
Second Resistance 115.27
Third Resistance 117.84
RSI 44.01
MFI 34.28
MACD Single Line -0.14
MACD -1.82
Support
First Resistance 106.94
Second Resistance 104.37
Third Resistance 101.49

Krebs Biochemicals & Industries Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 13,220 664,173 50.24
Week 11,813 806,814 68.3
1 Month 23,713 1,420,392 59.9
6 Month 32,182 1,630,649 50.67

Krebs Biochemicals & Industries Result Highlights

Krebs Biochemicals & Industries Synopsis

NSE-Medical-Generic Drugs

Krebs Biochemicals & belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 53.70 Cr. and Equity Capital is Rs. 19.62 Cr. for the Year ended 31/03/2021. Krebs Biochemicals & Industries Ltd. is a Public Limited Listed company incorporated on 02/12/1991 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110AP1991PLC103912 and registration number is 103912.
Market Cap 246
Sales 62
Shares in Float 0.58
No of funds 4
Yield
Book Value -10.12
U/D Vol ratio 2.6
LTDebt / Equity
Alpha -0.1
Beta 1.14

Krebs Biochemicals & Industries

Owner NameJun-22Mar-22Dec-21Sep-21
Promoters 72.74%72.74%72.74%
Foreign Portfolio Investors 0.01%0.01%0.01%
Financial Institutions/ Banks
Individual Investors 19.26%19.24%18.96%
Others 7.99%8.01%8.29%

Krebs Biochemicals & Industries Management

Name Designation
Dr. R T Ravi Chairman & Non-Exe.Director
Mr. Pabitrakumar Kalipada Bhattacharyya Managing Director
Mr. E J Babu Non Executive Director
Mr. G V L Prasad Independent Director
Mr. Raj Kamal Prasad Verma Independent Director
Dr. Tangirala Malati Independent Director
Mr. Satish Khivsara Independent Director
Mr. Avinash Ravi Director

Krebs Biochemicals & Industries Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Krebs Biochemicals & Industries Corporate Action

Date Purpose Remarks
2022-08-01 Quarterly Results
2022-05-23 Audited Results
2022-02-12 Quarterly Results
2021-11-09 Quarterly Results
2021-10-22 Preferential issue of shares

Krebs Biochemicals & Industries FAQs

What is Share Price of Krebs Biochemicals & Industries ?

Krebs Biochemicals & Industries share price is ₹114 As on 30 September, 2022 | 01:17

What is the Market Cap of Krebs Biochemicals & Industries ?

The Market Cap of Krebs Biochemicals & Industries is ₹246.9 Cr As on 30 September, 2022 | 01:17

What is the P/E ratio of Krebs Biochemicals & Industries ?

The P/E ratio of Krebs Biochemicals & Industries is -5.7 As on 30 September, 2022 | 01:17

What is the PB ratio of Krebs Biochemicals & Industries ?

The PB ratio of Krebs Biochemicals & Industries is -3.3 As on 30 September, 2022 | 01:17

Q1FY23